0001209191-18-005220.txt : 20180124 0001209191-18-005220.hdr.sgml : 20180124 20180124175953 ACCESSION NUMBER: 0001209191-18-005220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180122 FILED AS OF DATE: 20180124 DATE AS OF CHANGE: 20180124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Bradley L CENTRAL INDEX KEY: 0001400971 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 18546252 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-22 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001400971 Campbell Bradley L C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 0 1 0 0 Chief Operating Officer Common Stock 2018-01-22 4 M 0 32500 10.21 A 186600 D Common Stock 2018-01-22 4 S 0 32500 15.9191 D 154100 D Stock Options (right to buy) 10.21 2018-01-22 4 M 0 32500 0.00 D 2018-02-05 Common Stock 32500 0 D The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.73 to $16.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All of the options were fully vested and exercisable as of January 22, 2018. The options exercised were issued to Mr. Campbell in February 2008 and these options would have expired in February 2018. /s/ Bradley L. Campbell 2018-01-24